In addition, Dogru et al.[41] found that serum CD147 levels were significantly higher in patients with prostate cancer compared to healthy individuals by using ELISA, but there was no significant difference between men with prostate cancer and those without considering urinary CD147 levels. The gene discussed is BSG; the disease is prostate carcinoma.